Stocksigma LogoStocksigma Logo

Morepen Laboratories Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Lakh)

■ Revenue: 74,650 (+81.4% YoY | +30.9% QoQ) ■ EBITDA: 12,312 (+301.1% YoY | +49.2% QoQ) ■ EBITDA Margin (%): 16.5 (+903 bps YoY | +202 bps QoQ) ■ PAT

Morepen Laboratories Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Lakh)

Morepen Laboratories Ltd · Outcome · 27 Oct 2026, 7:01 pm

Morepen Laboratories Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Lakh) ■ Revenue: 74,650 (+81.4% YoY | +30.9% QoQ) ■ EBITDA: 12,312 (+301.1% YoY | +49.2% QoQ) ■ EBITDA Margin (%): 16.5 (+903 bps YoY | +202 bps QoQ) ■ PAT: 8,889 (+117.5% YoY | +57.6% QoQ) ■ EPS (INR): 1.62 (+116.0% YoY | +57.3% QoQ)

Original exchange filing (PDF)

More announcements from Morepen Laboratories Ltd

All Morepen Laboratories Ltd announcements